U.S. Telecom Services and Carriers Stock News

Schrödinger (SDGR) is back in focus after first quarter 2026 results combined a reported earnings miss with 12% growth in Annual Contract Value, along with fresh attention on its upcoming Bunsen AI co-scientist launch. See our latest analysis for Schrödinger. Recent trading reflects this renewed interest, with a 1 month share price return of 16.59% and 7 day share price return of 11.04%. However, the year to date share price return of negative 26.14% and 1 year total shareholder return of...

ACM Research (ACMR) opened 2026 with Q1 revenue of US$231.3 million and basic EPS of US$0.26, alongside trailing twelve month revenue of US$960.2 million and EPS of US$1.40 that frame the latest quarterly print. Over the past six quarters, the company has seen quarterly revenue range from US$172.3 million to US$269.2 million and basic EPS move between US$0.12 and US$0.56, giving investors a clear view of how top line and per share earnings have tracked into the current TTM profile. With...

CG Oncology (CGON) has just closed out FY 2025 with Q4 revenue of US$2.3 million and a basic EPS loss of US$0.52, alongside a net income loss of US$41.3 million, as the company continues to invest heavily in its pipeline. Over the last twelve months, revenue has summed to US$4.0 million and basic EPS has come in at a loss of US$2.08. This gives investors a clear view of a business that is still in a development phase and running with intentionally thin margins while it pushes its late stage...

If you are wondering whether Envista Holdings at US$24.29 offers good value or is already fully priced, the recent share performance gives you a useful starting point. The stock has pulled back 6.4% over the last 7 days and 4.0% over the last 30 days. It sits 12.0% higher year to date and 36.7% above where it was a year ago, while the 3 year and 5 year returns of 26.7% and 44.7% highlight a tougher longer term journey. Recent coverage has focused on Envista Holdings as a dental equipment and...

Earnings picture during a key regulatory phase Vera Therapeutics (VERA) reported a first quarter net loss of US$121.03 million, compared with US$51.69 million a year earlier, as it pushes atacicept toward potential approval for IgA nephropathy. Basic and diluted loss per share from continuing operations came in at US$1.69, versus US$0.81 in the prior year period. This provides a snapshot of how much capital the company is currently investing ahead of the July 7, 2026 FDA decision. See our...

What PNC’s Recent Returns Tell You PNC Financial Services Group (PNC) has moved in different directions across timeframes, with a 1 day return of about a 1.4% decline, losses over the past 3 months, and a 1 year total return of 35.9%. See our latest analysis for PNC Financial Services Group. Recent share price moves have cooled slightly, with a 30 day share price return of 2.5% against a 90 day share price return of a 9.6% decline, while the 1 year total shareholder return of 36.0% and 3...

Wondering if Labcorp Holdings at around US$258 a share still offers value, or if most of the opportunity is already priced in? This article walks through the key signals you can use to judge that for yourself. The stock has been fairly steady over the last week with a 0.5% return, has a 4.1% decline over the past month, yet sits on a 4.8% return over 1 year and 41.6% over 3 years. This raises the question of whether the current price reflects the business fundamentals. Recent headlines...

Ubiquiti (UI) has put up another big quarter, with Q2 2026 revenue of US$814.9 million and basic EPS of US$3.86, while trailing 12 month EPS sits at US$14.69 on revenue of about US$3.0 billion and earnings growth over that period is described as a 99.7% jump. The company has seen quarterly revenue move from US$599.9 million and EPS of US$2.26 in Q2 2025 to US$814.9 million and EPS of US$3.86 in Q2 2026, and trailing 12 month net profit margin is now stated at 29.9% versus 20.7% a year...

Navios Maritime Partners L.P. recently announced that its Board of Directors approved a cash distribution of US$0.06 per unit for the quarter ended March 31, 2026, a 20% increase over the prior quarter, payable on May 14, 2026 to holders of record as of May 11, 2026. This higher quarterly payout, equivalent to an annualized US$0.24 per unit, highlights management’s willingness to return more cash to unitholders and may influence how investors assess its income profile. We will now examine...

Goodyear Tire & Rubber (GT) reported first quarter 2026 results, with sales of US$3,881 million and a net loss of US$249 million, as tyre volumes and input costs weighed on performance. See our latest analysis for Goodyear Tire & Rubber. At a share price of US$6.86, Goodyear’s 1 day share price return of 6.03% decline and 7 day share price return of 3.11% decline came after the first quarter loss and ongoing cost pressures. The 1 year total shareholder return of 37.29% decline underlines that...

Wondering whether Clover Health Investments at US$2.82 is still a bargain or already pricing in its prospects? This breakdown will help you judge what you are really paying for. The stock has had a strong run over shorter periods, with returns of 2.5% over 7 days, 48.4% over 30 days and 17.0% year to date. However, the 1 year return sits at a 24.8% decline and the 3 year return is very large at 196.7% compared to a 61.2% decline over 5 years. Recent headlines have focused on the company as a...

Lyft (LYFT) closed FY 2025 with fourth quarter revenue of US$1,592.7 million and basic EPS of US$6.88, setting a high bar for a year in which trailing 12 month EPS reached US$6.92 and revenue stood at US$6.3 billion alongside very large year over year earnings growth and a 45% net profit margin. Over the past six quarters, the company has seen quarterly revenue move from US$1,522.7 million in Q3 2024 to between US$1,450.2 million and US$1,685.2 million across FY 2025, while basic EPS ranged...

Recent performance snapshot for VNET Group (NasdaqGS:VNET) With no single headline event driving attention, VNET Group (NasdaqGS:VNET) is back on investors’ radar after mixed recent returns and improving annual revenue and net income figures, which contrast with its current loss-making position. See our latest analysis for VNET Group. VNET Group’s share price has been choppy, with a 7.82% 7 day share price return and 12.70% 30 day share price return contrasting with a 20% 90 day share price...

In the first quarter ended March 31, 2026, Xenon Pharmaceuticals reported a net loss of US$102.3 million, or US$1.17 per share, while highlighting that it still has no marketed products and relies on collaboration revenues. More importantly for the company’s evolution, Xenon released positive Phase 3 X-TOLE2 data for its epilepsy candidate azetukalner and outlined plans to submit a New Drug Application to the FDA in the third quarter of 2026, underpinned by an expanded cash position of...

CoreWeave (CRWV) has just wrapped up FY 2025 with Q4 total revenue of US$1.6b, a basic EPS loss of US$0.89 and net income loss of US$452.0m. This caps off a year in which trailing twelve month revenue reached US$5.1b alongside a TTM basic EPS loss of US$2.75. Over the past six reported quarters, the company has seen revenue move from US$584.0m in Q3 2024 to US$1.6b in Q4 2025. During the same period, quarterly basic EPS has ranged between a loss of US$0.22 and a loss of US$1.82, so the latest...

What Moelis’ latest filings mean for stock watchers Moelis (MC) just combined a softer first quarter, fresh buyback data, a maintained cash dividend, and new shelf registrations for Class A shares, giving you several moving pieces to weigh at once. See our latest analysis for Moelis. After these filings and the softer first quarter, Moelis is trading at US$63.91, with a 30 day share price return of 11.15% but a 10.26% decline year to date. The 1 year total shareholder return of 19.41% and 3...

If you are wondering whether Murphy Oil at around US$38.27 is offering value or just riding momentum, the recent share performance gives you plenty to think about. The stock has seen a 1 year return of 88.2% and is up 17.8% year to date, despite shorter term pullbacks with a 7 day return showing an 8.4% decline and a 30 day return showing a 10.5% decline. Recent coverage has focused on Murphy Oil as part of broader conversations around US oil and gas stocks, with attention on how producers...

How Patterson-UTI Energy Stock Has Been Performing Patterson-UTI Energy (PTEN) has drawn attention after a strong year, with the stock up about 76% year to date and delivering a total return of roughly 106% over the past 12 months. Over shorter periods, performance has been mixed, with a 1% decline in the last session, a 7% decline over the past week, and small gains over the past month, while the past 3 months show a return of about 32%. See our latest analysis for Patterson-UTI Energy. The...

Genpact (G) has wrapped up FY 2025 with fourth quarter revenue of about US$1.3 billion and basic EPS of US$0.83, alongside trailing twelve month revenue of roughly US$5.1 billion and EPS of US$3.18, with earnings over the past year reported as growing 7.6%. Over recent periods the company has seen quarterly revenue move from US$1,248.7 million and EPS of US$0.81 in Q4 FY 2024 to US$1,319.3 million and EPS of US$0.83 in Q4 FY 2025. Trailing twelve month net income sits at US$552.5 million and...

NGL Energy Partners (NGL) is back in focus after outlining a Lea County Express Pipeline expansion in New Mexico, paired with a $100 million unit buyback and a new $950 million term loan facility. See our latest analysis for NGL Energy Partners. The stock has climbed toward a new 52 week high at a share price of $16.13, with a 30 day share price return of 25.92% and a very large 1 year total shareholder return. This suggests that recent pipeline and financing news may be reshaping investor...

In recent days, Champion Homes was caught in a broad homebuilding sector selloff after renewed Middle East tensions pushed Treasury yields, mortgage rates, and oil prices higher, raising concerns about housing affordability and construction costs. The pullback highlights how sensitive factory-built housing producers like Champion are to shifts in long-term interest rates and homebuyer confidence, even when there is no company-specific news. Against this backdrop of rising long-term rates...

In late April 2026, UMB Financial reported significantly higher first-quarter results than a year earlier, including net interest income of US$534.37 million and net income of US$261.44 million, while also affirming common and preferred dividends, launching a new buyback authorization of up to 2,000,000 shares, and filing a US$372.66 million ESOP-related common stock shelf registration. An interesting angle for investors is that UMB Financial combined materially stronger earnings and lower...

Jacobs Solutions (J) has drawn fresh attention after reporting Q2 2026 results that paired organic net revenue growth and margin expansion with raised full year guidance and strong demand in AI and data center infrastructure. See our latest analysis for Jacobs Solutions. Even with the upbeat Q2 update and fresh contract wins in Nashville and Sydney, the stock has lost ground recently, with a 90 day share price return of 17.51% and year to date share price return of 9.30%, while the 3 year...

In early May 2026, Ocugen reported first-quarter revenue of US$1.53 million alongside a net loss of US$19.18 million, while also closing a US$115 million private offering of 6.75% Convertible Senior Notes due 2034 and using about US$32.7 million to retire its Avenue loan. These updates both highlight Ocugen’s ongoing cash burn and materially improve its liquidity profile, with management indicating the new financing extends the company’s cash runway and supports continued advancement of its...